Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
13 November, 2018 10:23 IST
'Subscribe' to Equitas Holdings IPO: Reliance Sec
Source: IRIS | 04 Apr, 2016, 03.11PM
Comments  |  Post Comment

Equitas Holding is a leading player in microfinance segment with approx 5.5% market share. The company also operates in pre-owned vehicle, MSE and affordable housing segments. The company is in the process of converting itself into a Small Finance Banks (SFB), which gives the company access to low-cost funds coupled with wider scope of cross selling opportunities.

Reliance Securities has recommended 'Subscribe' to IPO of Equitas Holdings. Commenting on the investment rationale, the stock broker said, ''Post the fresh issue of Rs 7.2 billion the company will be trading at a valuation of 1.8x P/ABV which looks reasonable considering its strong growth potential. However, Equitas SFB may witness a fall in its RoA and RoE in medium term due to transition into SFB.

We expect the new bank to deliver ROA of above 2% in next 2-3 years. Although, FII will not able to participate in the IPO but they can acquire the stock post listing, as post listing FII holding will fall below the 49% limit set by the RBI for SFBs. This may inturn create liquidity and fresh buying support on the counter upon listing. We suggest Subscribe from a long term perspective.''

Disclaimer: IRIS has taken due care and caution in compilation of data for its web site. Information has been obtained by IRIS from sources which it considers reliable. However, IRIS does not guarantee the accuracy, adequacy or completeness of any information and is not responsible for any errors or omissions or for the results obtained from the use of such information. IRIS especially states that it has no financial liability whatsoever to any user on account of the use of information provided on its website.

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Suven Life Sciences secures product Patents in Australia and Hong Kong - 13-Nov-2018 10:18
GAIL Gas signs MoU with EESL - 13-Nov-2018 10:14
Lupin launches generic Atovaquone oral suspension in US - 12-Nov-2018 16:06
Zydus Cadila gets USFDAs nod for anti-fungal ointment - 12-Nov-2018 13:40
NHB sanctions Rs 35 bn refinance facility to PNB Housing Finance - 12-Nov-2018 13:17
BHEL commissions 120 MW Pulichintala hydro-electric project - 12-Nov-2018 12:55
Tata Consultancy Services partners with ENGIE Laborelec - 12-Nov-2018 12:52
Lupin gets establishment inspection report for Nagpur unit - 12-Nov-2018 09:56
GAIL fast tracks North East feeder gas pipeline project - 12-Nov-2018 09:43
Biocon's new generic facility in Bengaluru completes inspection - 12-Nov-2018 09:35
Cipla gets USFDA final approval for Valganciclovir tablets - 12-Nov-2018 09:32
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer